{"DataElement":{"publicId":"2729182","version":"1","preferredName":"PET Isotope Labeled Metabolite (FES) Flux Number","preferredDefinition":"The measurement where the blood clearance curve has been corrected for the labeled metabolites.   [Manually-curated]","longName":"ISOTOP_FES_FLUX_NUM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2729167","version":"1","preferredName":"PET Isotope Labeled Metabolite Flux","preferredDefinition":"The movement of a radioactive tracer tag involved in cell metabolism through the cell membrane.","longName":"PET_ISOTOP_FES_FLUX","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2688012","version":"1","preferredName":"Positron Emission Tomography Isotope","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:Substances having the same number of protons in their nuclei and hence having the same atomic number, but differing in the number of neutrons and therefore, in the mass number.","longName":"C17007:C47933","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Isotope","conceptCode":"C47933","definition":"A form of a chemical element containing a specific number of neutrons and a specific atomic mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BFD207C-BCF8-656B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-10-08","modifiedBy":"ONEDATA","dateModified":"2007-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2729165","version":"1","preferredName":"Labeled Metabolite Flux","preferredDefinition":"Bearing or marked with a label or tag.:Any substance involved in metabolism, either as a product of metabolism or as necessary for metabolism. :Movement of a substance through a unit area of a boundary layer or membrane per unit of time.","longName":"C43386:C61154:C72076","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Labeled","conceptCode":"C43386","definition":"Bearing or marked with a label or tag.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metabolite","conceptCode":"C61154","definition":"Any substance involved in metabolism, either as a product of metabolism or as necessary for metabolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Flux","conceptCode":"C72076","definition":"Movement of a substance through a unit area of a boundary layer or membrane per unit of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4623C546-AA37-0F82-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-14","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-14","modifiedBy":"ONEDATA","dateModified":"2008-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4623C546-AA48-0F82-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-14","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"2/19/08 - released  2/14/08- Created to support curation of ACRIN PET CDEs; Univ of WASH FES, FMISO studies.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2729174","version":"1","preferredName":"F-18 16 Alpha-Fluoroestradiol (FES) Flux Number","preferredDefinition":"A quantity to capture the amount of movement of radiolabeled estradiol through the cell membrane per unit of time.  [Manually-curated]","longName":"FES_FLUX_NUM","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"3","format":"9.999","PermissibleValues":[],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2730303","version":"1","preferredName":"F-18 16 Alpha-Fluoroestradiol Flux Number","preferredDefinition":"A radiopharmaceutical containing an estradiol analog radiolabeled with fluorine F 18, a positron emitting isotope, used as a tracer in positron emission tomography (PET). F-18 16 alpha-fluoroestradiol is actively taken up in tumor cells expressing the estrogen receptor (ER), thereby allowing visualization of ER-positive cells upon PET. The uptake of F-18 16 alpha-fluoroestradiol is dependent upon changes in ER levels in the target tissue.:Movement of a substance through a unit area of a boundary layer or membrane per unit of time.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C62541:C72076:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"F-18 16 Alpha-Fluoroestradiol","conceptCode":"C62541","definition":"A radiopharmaceutical consisting of an estradiol analogue radiolabeled with the positron-emitting isotope fluorine F 18. F-18 16 alpha-fluoroestradiol is actively taken up in tumor cells expressing the estrogen receptor (ER), allowing visualization of ER-positive tumor cells with positron emission tomography (PET). Uptake of this agent depends upon the ER status of target tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Flux","conceptCode":"C72076","definition":"Movement of a substance through a unit area of a boundary layer or membrane per unit of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4687366D-185C-6FE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-19","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-19","modifiedBy":"ONEDATA","dateModified":"2008-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46251057-AE0A-1A81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-14","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-14","modifiedBy":"CHILLIJ","dateModified":"2008-02-19","changeDescription":"2/14/08 - created for Univ of Washington FES study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"},{"publicId":"2812734","version":"1","longName":"U Washington New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"FES Flux","type":"Preferred Question Text","description":"FES Flux","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4625789A-4AC4-3069-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-14","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-14","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support U Washington adoption of C3D for FES trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}